あなたのバッジ 52週レンジ $11–$34 85% of range アナリスト評価 HOLD 19 analysts 目標株価 $35 +14% upside P/E 21.3 ROE 34.3% 純利益率 3.6%

OSCR 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ

03
株価 $30.94
P/E (TTM) 21.3
EPS (TTM) $1.45
収益 (TTM) $15.32B
ROE (TTM) 34.3%
負債/自己資本 (MRQ) 0.2
52週レンジ $11–$34

OSCR 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ

04
範囲
バー

バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。

Oscar Health, Inc. Class A Common Stock について Wikipediaからの企業概要

05 · wikidata

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗

Wikidata ↗

セクターFinancials 業種Insurance 従業員2,305 国US

10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド

06
収益$11.70B
2019-12-31 → 2025-12-31
EPS$-1.69
2019-12-31 → 2025-12-31
フリーキャッシュフロー$1.06B
2021-12-31 → 2025-12-31
純利益率3.6%
2021-12-31 → 2025-12-31
バリュエーションと指標 07–12

バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?

指標 5年トレンド OSCR 5年平均 競合中央値 結論
P/E (TTM) 21.35年平均 ≈23.0 ≈23.0 15.4 割高

同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。

バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価

決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日

14
平均サプライズ 24.3%
次回決算 11月 04, 2026
期間レポートEPS ActualEPS 予想サプライズ
2026年6月30日 8月 6, 2026 $1.10 $0.39 179.5%
2026年3月31日 $2.07 $1.21 71.5%
2025年12月31日 $-1.24 $-0.91 -37.0%
2025年9月30日 $-0.53 $-0.57 6.6%
2025年6月30日 $-0.89 $-0.47 -88.5%
2025年3月31日 $0.92 $0.81 13.8%

完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー

15
損益計算書 13
指標 トレンド 202520242023202220212020
Revenue $11.70B$9.18B$5.86B$3.96B$1.84B$463M
SG&A Expense $2.05B$1.76B$1.43B$1.26B$265M$167M
Operating Income $-396M$57M$-236M$-590M$-544M$-402M
Interest Expense ··$25M$23M$5M$4M
Other Non-op $-23M$-105.0K$-7M$2M$-1M·
Pretax Income $-437M$33M$-267M$-610M$-571M$-406M
Income Tax $6M$7M$3M$-523.0K$846.0K$1M
Net Income $-443M$25M$-271M$-606M$-573M$-407M
EPS (Basic) $-1.69$0.11$-1.22$-2.85$-3.20$-14.16
EPS (Diluted) $-1.69$0.10$-1.22$-2.85$-3.20$-14.16
Shares (Basic) 262,388,000240,386,000221,655,000212,475,000178,967,05629,263,424
Shares (Diluted) 262,388,000265,853,000221,655,000212,475,000178,967,05629,263,424
EBITDA $-367M$89M$-205M·$-530M·
貸借対照表 23
指標 トレンド 202520242023202220212020
Cash & Equivalents $2.77B$1.53B$1.87B$1.56B$1.10B$826M
Short-term Investments ·$624M$690M···
Receivables $363M·····
Other Current Assets $24M$21M$7M$6M$4M·
Current Assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B
PP&E (Net) $88M$67M$62M$60M$47M$36M
PP&E (Gross) $230M$181M$150M$117M$89M$63M
Accum. Depreciation $142M$114M$88M$57M$42M$27M
Other Non-current Assets $120M$82M$83M$95M$97M$13M
Total Assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Accounts Payable $507M$432M$273M$298M$235M$138M
Current Liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B
Capital Leases $52M$61M$67M$72M$77M·
Other Non-current Liabilities $52M$61M$68M$72M$77M$0
Total Liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B
Total Debt $430M$300M$299M·$0·
Common Stock ·····$2.0K
Paid-in Capital $4.26B$3.87B$3.68B$3.51B$3.39B$133M
Retained Earnings $-3.29B$-2.85B$-2.88B$-2.61B$-2.00B$-1.43B
Treasury Stock $3M$3M$3M$3M$3M$3M
AOCI $18M$-2M$1M$-10M$-4M$879.0K
Stockholders' Equity $978M$1.01B$804M$890M$1.39B$-1.30B
Liabilities + Equity $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
キャッシュフロー 16
指標 トレンド 202520242023202220212020
D&A $29M$32M$31M$15M$15M$11M
Stock-based Comp $88M$110M$160M$112M$86M$36M
Deferred Tax $2M$-2M$58.0K$-165.0K$-101.0K$-67.0K
Other Non-cash $1.42B$813M$-192M·$290M·
Operating Cash Flow $1.09B$978M$-272M$380M$-182M$223M
CapEx $36M$28M$26M$29M$26M$14M
Investing Cash Flow $-241M$-1.39B$577M$-227M$-775M$-345M
Debt Issued $410M$0$0$305M$0$147M
Net Debt Issued $410M$0$0···
Stock Repurchased ····$0$0
Net Stock Activity ····$0·
Financing Cash Flow $399M$68M$6M$301M$1.24B$612M
Net Change in Cash $1.25B$-341M$311M$455M$282M$490M
Taxes Paid $18M$674.0K$2M$2M$697.0K$2M
Free Cash Flow $1.06B$950M$-298M·$-208M·
Levered FCF ··$-323M·$-212M·
収益性 7
指標 トレンド 202520242023202220212020
Operating Margin -3.4%0.62%-4.0%·-29.6%·
Net Margin -3.8%0.28%-4.6%·-31.1%·
Pretax Margin -3.7%0.36%-4.6%·-31.0%·
EBITDA Margin -3.1%0.97%-3.5%·-28.8%·
ROA -7.9%0.60%-6.7%·-20.5%·
ROE -44.5%2.8%-32.0%·-36.7%·
ROIC -28.5%3.4%-21.6%·-39.3%·
流動性と支払能力 5
指標 トレンド 202520242023202220212020
Current Ratio 0.90.81.3·1.2·
Quick Ratio 0.60.60.8·0.6·
Debt / Equity 0.40.30.4·0.0·
LT Debt / Equity 0.40.30.4·0.0·
Interest Coverage ··-9.6·-115.4·
効率性 1
指標 トレンド 202520242023202220212020
Asset Turnover 2.12.21.4·0.7·
1株あたり 3
指標 トレンド 202520242023202220212020
Revenue / Share $44.60$34.52$26.45·$10.27·
Cash Flow / Share $4.17$3.68$-1.23·$-1.02·
EPS (TTM) $-1.69$0.10$-1.22$-2.85$-3.20·
成長率 3
指標 トレンド 202520242023202220212020
Revenue YoY 27.5%56.5%47.9%115.6%297.3%·
Revenue CAGR 3Y 43.5%70.9%133.1%···
Revenue CAGR 5Y 90.8%·····
バリュエーション(TTM) 4
指標 トレンド 202520242023202220212020
Revenue TTM $11.70B$9.18B$5.86B$3.96B$1.84B·
Net Income TTM $-443M$25M$-271M$-606M$-573M·
P/E -8.5134.4-7.5-0.9-2.5·
Earnings Yield -11.8%0.74%-13.3%-115.9%-40.8%·

最新期間は左側 · null値は・として表示

財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間

16
指標 2025-12-312024-12-312023-12-312022-12-312021-12-31
収益 $11.70B $9.18B $5.86B $3.96B $1.84B
営業利益率 % -3.4% 0.62% -4.0% · -29.6%
純利益 $-443M $25M $-271M $-606M $-573M
希薄化後EPS $-1.69 $0.10 $-1.22 $-2.85 $-3.20

機関投資家(13F) 459 提出者 · $6.2B合計 · 時点 2026年9月30日

17

四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。

保有者 459
保有価値 $6.2B
新規ポジション 125
解消済みポジション 46
機関投資家の動向 — Q2 2026 対 前四半期
新規ポジション 解消済みポジション 増加 減少 純株式数増減
125 (+51 前期比) 46 (-18 前期比) 147 (+22 前期比) 115 (+3 前期比) +22.8M

Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。

機関投資家 評価額 株式数 % 追跡された13Fのうち タイプ
BlackRock, Inc. $587,153,449 20,587,428 9.50% 株式数
D. E. Shaw & Co., Inc. $360,595,957 12,643,617 5.84% 株式数
VANGUARD PORTFOLIO MANAGEMENT LLC $314,559,172 11,029,424 5.09% 株式数
VANGUARD CAPITAL MANAGEMENT LLC $301,725,543 10,579,437 4.88% 株式数
VANGUARD GROUP INC $297,476,962 20,701,250 4.82% 株式数
AMERICAN CENTURY COMPANIES INC $258,255,502 9,055,242 4.18% 株式数
JANE STREET GROUP, LLC $181,530,912 6,365,039 2.94% 株式数
Thrive Capital Management, LLC $180,919,957 6,343,617 2.93% 株式数
GEODE CAPITAL MANAGEMENT, LLC $165,994,311 5,819,186 2.69% 株式数
STATE STREET CORP $165,454,531 5,801,351 2.68% 株式数
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162,917,648 5,712,400 2.64% コールオプション
FMR LLC $142,557,861 4,998,523 2.31% 株式数
CITADEL ADVISORS LLC $120,626,823 4,229,552 1.95% 株式数
TWO SIGMA INVESTMENTS, LP $115,097,850 4,035,689 1.86% 株式数
DIMENSIONAL FUND ADVISORS LP $101,885,043 3,571,731 1.65% 株式数
BIT Capital GmbH $97,480,134 3,417,957 1.58% 株式数
RENAISSANCE TECHNOLOGIES LLC $93,673,940 3,284,500 1.52% 株式数
JACOBS LEVY EQUITY MANAGEMENT, INC $86,282,012 3,025,316 1.40% 株式数
GLYNN CAPITAL MANAGEMENT LLC $73,462,615 2,575,828 1.19% 株式数
CITADEL ADVISORS LLC $72,469,320 2,541,000 1.17% コールオプション
GOLDMAN SACHS GROUP INC $65,298,165 2,289,557 1.06% 株式数
NORTHERN TRUST CORP $63,063,680 2,211,209 1.02% 株式数
WOLVERINE ASSET MANAGEMENT LLC $61,825,656 2,167,800 1.00% プットオプション
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60,458,493 2,119,863 0.98% 株式数
MORGAN STANLEY $60,299,272 2,114,280 0.98% 株式数
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55,351,616 1,940,800 0.90% プットオプション
JANE STREET GROUP, LLC $53,968,396 1,892,300 0.87% コールオプション
Nuveen, LLC $50,501,648 1,770,745 0.82% 株式数
BlackBarn Capital Partners LP $49,910,000 1,750,000 0.81% プットオプション
BNP PARIBAS FINANCIAL MARKETS $48,660,710 1,706,196 0.79% 株式数
VANGUARD FIDUCIARY TRUST CO $45,996,029 1,612,764 0.74% 株式数
CITADEL ADVISORS LLC $44,459,828 1,558,900 0.72% プットオプション
STATE OF MICHIGAN RETIREMENT SYSTEM $41,354,000 1,450,000 0.67% 株式数
BANK OF AMERICA CORP /DE/ $37,594,294 1,318,173 0.61% 株式数
Assenagon Asset Management S.A. $35,592,732 1,247,992 0.58% 株式数
TWO SIGMA ADVISERS, LP $35,534,136 2,472,800 0.58% 株式数
UBS Group AG $34,596,357 1,213,056 0.56% 株式数
JANE STREET GROUP, LLC $33,796,200 1,185,000 0.55% プットオプション
GROUP ONE TRADING LLC $32,744,154 1,148,112 0.53% 株式数
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31,200,652 1,093,992 0.51% 株式数
Qube Research & Technologies Ltd $30,913,940 1,083,939 0.50% 株式数
TUDOR INVESTMENT CORP ET AL $29,055,948 1,018,792 0.47% 株式数
GILDER GAGNON HOWE & CO LLC $28,576,515 1,001,982 0.46% 株式数
JPMORGAN CHASE & CO $26,387,407 885,558 0.43% 株式数
FEDERATED HERMES, INC. $26,096,200 915,014 0.42% 株式数
WELLS FARGO & COMPANY/MN $23,408,907 820,789 0.38% 株式数
Walleye Capital LLC $23,243,058 814,974 0.38% 株式数
Point72 Asset Management, L.P. $22,809,212 799,762 0.37% 株式数
Walleye Trading LLC $22,744,700 797,500 0.37% コールオプション
Bank of New York Mellon Corp $22,032,138 772,515 0.36% 株式数

459件の機関投資家をすべて表示 →

アクティビストおよび5%超のオーナー 2保有

18

SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。

提出者 提出済み 保有 ステータス 目的 提出書類
Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC 2026年9月18日 12.10% 修正 · SEC
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 提出書類 2024年11月13日 · 初回提出 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

企業インサイダー 23 人のインサイダー · 12人の役員 · 12人の取締役

19
インサイダー 役職 最終アクティビティ 保有株式数 12ヶ月購入 12ヶ月売却 12ヶ月純額
Mark T Bertolini Chief Executive Officer 2026年6月30日 S 7,751,570 1 8 $-58,759,399
Richard Scott Blackley Chief Financial Officer 2026年9月3日 S 1,046,108 0 9 $-7,941,907
Janet Liang President, Oscar Insurance 2026年9月3日 S 248,697 0 5 $-821,072
Steven Wolin Chief Operating Officer 2024年12月1日 M 102,598 0 0 $0
Meghan V. Joyce Chief Operating Officer 2022年3月1日 M 43,070 0 0 $0
Joshua Kushner Co-Founder and Vice Chairman 2026年9月18日 J 0 0 0 $0
Victoria Baltrus Chief Accounting Officer 2026年9月3日 S 213,631 0 5 $-194,480
Adam Mcananey Chief Legal Officer 2026年9月3日 S 209,004 0 5 $-783,513
Alessandrea C. Quane EVP, Chief Insurance Officer 2024年12月5日 M 430,216 0 0 $0
Ranmali Bopitiya EVP & Chief Legal Officer 2024年12月1日 M 241,488 0 0 $0
Dennis Weaver Chief Clinical Officer 2022年12月1日 M 27,110 0 0 $0
Joel Klein Chief Policy & Strat. Officer 2021年8月18日 M 17 0 0 $0
Vanessa Ames Wittman 取締役 2026年9月18日 S 112,121 0 1 $-806,000
Mario Schlosser 取締役 2026年9月3日 S 449,444 0 29 $-68,790,950
William Gassen 取締役 2026年7月9日 A 82,840 0 0 $0
David Plouffe 取締役 2026年7月9日 A 137,121 0 0 $0
Sid Sankaran 取締役 2026年7月9日 A 22,609 0 0 $0
Laura W Lang 取締役 2026年6月4日 A 82,840 0 0 $0
Jeffery H Boyd 取締役 2026年4月9日 A 705,673 0 0 $0
Elbert O. Robinson Jr. 取締役 2025年5月12日 S 64,512 0 0 $0
Jr Charles E Phillips 取締役 2022年10月14日 A 85,787 0 0 $0
Teri List-Stoll 取締役 2021年3月5日 A 50,000 0 0 $0
Ari Fischel · 2021年3月5日 A 0 0 0 $0

SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ

ETF保有状況 46のETFが保有

20

ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。

ファンド ウェイト 単位 時点 ソース
ABLS · Abacus FCF ETF Trust 5.83% 867 NS 2026年7月31日 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1.98% 235,668 SH 2026年10月1日 日次
RNIN · EA Series Trust 1.20% 70,047 NS 2026年7月31日 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.74% 307,696 NS 2026年7月31日 N-PORT
JSML · Janus Detroit Street Trust 0.60% 69,666 NS 2026年7月31日 N-PORT
IWO · iShares Trust 0.52% 2,269,828 SH 2026年9月11日 日次
JSMD · Janus Detroit Street Trust 0.51% 171,181 NS 2026年7月31日 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0.45% 58,846 SH 2026年10月1日 日次
VTWG · VANGUARD SCOTTSDALE FUNDS 0.40% 258,034 SH 2026年8月19日 日次
FYX · First Trust Exchange-Traded AlphaDE… 0.35% 152,933 NS 2026年7月31日 N-PORT
BKSE · BNY Mellon ETF Trust 0.31% 8,798 NS 2026年7月31日 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.27% 61,099 NS 2026年7月31日 N-PORT
FYEE · Fidelity Greenwood Street Trust 0.27% 19,102 NS 2026年7月31日 N-PORT
IWM · iShares Trust 0.26% 6,175,602 SH 2026年9月11日 日次
FBUF · Fidelity Greenwood Street Trust 0.25% 1,889 NS 2026年7月31日 N-PORT
ISCG · iShares Trust 0.24% 71,367 SH 2026年9月11日 日次
RSSL · Global X Funds 0.24% 115,406 NS 2026年7月31日 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.21% 1,387,125 SH 2026年8月19日 日次
FHEQ · Fidelity Greenwood Street Trust 0.21% 61,010 NS 2026年7月31日 N-PORT
VBK · VANGUARD INDEX FUNDS 0.19% 3,171,535 SH 2026年8月19日 日次
PRFZ · Invesco Exchange-Traded Fund Trust 0.17% 148,826 SH 2026年10月1日 日次
DFAS · Dimensional ETF Trust 0.16% 805,292 NS 2026年7月31日 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.15% 27,872 NS 2026年7月31日 N-PORT
ESML · iShares Trust 0.11% 96,895 SH 2026年9月11日 日次
FNCL · FIDELITY COVINGTON TRUST 0.08% 61,975 NS 2026年7月31日 N-PORT
VB · VANGUARD INDEX FUNDS 0.08% 5,488,922 SH 2026年8月19日 日次
VFH · VANGUARD WORLD FUND 0.08% 384,466 SH 2026年8月19日 日次
WSML · iShares Trust 0.07% 14,630 SH 2026年9月11日 日次
VXF · VANGUARD INDEX FUNDS 0.07% 2,534,194 SH 2026年8月19日 日次
IUS · Invesco Exchange-Traded Self-Indexe… 0.04% 12,473 SH 2026年10月1日 日次
DFSU · Dimensional ETF Trust 0.03% 20,892 NS 2026年7月31日 N-PORT
DCOR · Dimensional ETF Trust 0.02% 21,472 NS 2026年7月31日 N-PORT
DFAC · Dimensional ETF Trust 0.02% 286,808 NS 2026年7月31日 N-PORT
TILT · FlexShares Trust 0.02% 12,166 NS 2026年7月31日 N-PORT
DFAU · Dimensional ETF Trust 0.01% 50,403 NS 2026年7月31日 N-PORT
IWV · iShares Trust 0.01% 64,590 SH 2026年9月11日 日次
VTI · VANGUARD INDEX FUNDS 0.01% 7,601,113 SH 2026年8月19日 日次
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 194,738 SH 2026年8月19日 日次
VTHR · VANGUARD SCOTTSDALE FUNDS 0.01% 19,808 SH 2026年8月19日 日次
DFUS · Dimensional ETF Trust 0.01% 66,708 NS 2026年7月31日 N-PORT
ESGV · VANGUARD WORLD FUND 0.01% 53,203 SH 2026年8月19日 日次
ITOT · iShares Trust 0.01% 287,602 SH 2026年9月11日 日次
DXUV · Dimensional ETF Trust 0.00% 472 NS 2026年7月31日 N-PORT
IAK · iShares Trust · 117,671 SH 2026年9月11日 日次
ISCB · iShares Trust · 10,063 SH 2026年9月11日 日次
SMLF · iShares Trust · 286,871 SH 2026年9月11日 日次

OSCR アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド

21
レーティング · 19 アナリスト 買い
中央値ターゲット $33.50 +8.3%
2 10.5% 強い買い
7 36.8% 買い
9 47.4% 保有
1 5.3% 売り
0 0.0% 強い売り

12ヶ月目標株価

10 アナリスト · 2026-10-03

平均値ターゲット $35.40 +14.4%

現在 現在価格 $30.94
安値$26.00 平均値$35.40 高値$49.00

同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較

22

FY基準、価格は各社の直近年度末終値。

ティッカー 時価総額 P/E 売上高 YoY 純利益率 ROE 粗利益率
OSCR · -8.5 27.5% -3.8% -44.5% ·
AFL $57.20B 16.2 -9.3% 21.2% 12.9% ·
PRU · · · · · ·
PFG $19.18B 16.8 -3.1% 7.6% 10.3% ·
UNM · · · · · ·
GL $12.90B 9.9 3.7% 19.4% 20.4% ·
PRI $8.22B 11.3 6.6% 22.8% 31.9% ·
LNC $8.46B 7.6 -1.2% 6.5% 12.3% ·
CNO $4.01B 18.5 0.85% 5.1% 8.9% ·

最新ニュース この会社に言及した最近の見出し

23

マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行

26

重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。

選択内容は保存され、すべてのティッカーで引き継がれます。

出典:SEC 10-Q 提出日 8月 7, 2026